1 TAMSULOSIN HCL | 70 of 240 | 6650 prescriptions Less than 1% of all prescriptions | 5910 | 1670 patients 31% of all patients | 1520 patients 28% of all patients | |
2 FINASTERIDE | 60 of 240 | 2900 prescriptions Less than 1% of all prescriptions | | 750 patients 14% of all patients | < 11 | |
3 OXYBUTYNIN CHLORIDE ER (OXYBUTYNIN CHLORIDE) | 40 of 200 | 2240 prescriptions Less than 1% of all prescriptions | 1960 | 510 patients 9% of all patients | < 11 | |
4 DUTASTERIDE | 40 of 130 | 770 prescriptions Less than 1% of all prescriptions | 770 | 200 patients 4% of all patients | 200 patients 4% of all patients | |
5 MYRBETRIQ (MIRABEGRON) | 70 of 230 | 1070 prescriptions Less than 1% of all prescriptions | 950 | 300 patients 6% of all patients | < 11 | |
6 ALFUZOSIN HCL ER (ALFUZOSIN HCL) | 100 of 170 | 410 prescriptions Less than 1% of all prescriptions | 410 | 110 patients 2% of all patients | 110 patients 2% of all patients | |
7 VESICARE (SOLIFENACIN SUCCINATE) | 40 of 170 | 630 prescriptions Less than 1% of all prescriptions | | 130 patients 2% of all patients | < 11 | |
8 ELMIRON (PENTOSAN POLYSULFATE SODIUM) | 10 of 40 | 940 prescriptions Less than 1% of all prescriptions | | 130 patients 2% of all patients | < 11 | |
9 DOXAZOSIN MESYLATE | 60 of 160 | 320 prescriptions Less than 1% of all prescriptions | 320 | < 11 | < 11 | |
10 BICALUTAMIDE | 50 of 150 | 400 prescriptions Less than 1% of all prescriptions | 400 | < 11 | < 11 | |
11 CIALIS (TADALAFIL) | 20 of 120 | 340 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 TOLTERODINE TARTRATE ER (TOLTERODINE TARTRATE) | 70 of 130 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 OXYBUTYNIN CHLORIDE | 50 of 150 | 400 prescriptions Less than 1% of all prescriptions | | 220 patients 4% of all patients | < 11 | |
14 NITROFURANTOIN (NITROFURANTOIN MACROCRYSTAL) | 20 of 90 | 1050 prescriptions Less than 1% of all prescriptions | | 690 patients 13% of all patients | < 11 | A |
15 DUTASTERIDE-TAMSULOSIN (DUTASTERIDE/TAMSULOSIN HCL) | 40 of 60 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
16 TOVIAZ (FESOTERODINE FUMARATE) | 70 of 140 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 POTASSIUM CITRATE ER (POTASSIUM CITRATE) | 60 of 130 | 220 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
18 ANDROGEL (TESTOSTERONE) | 40 of 100 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 METHENAMINE HIPPURATE | 50 of 70 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
20 CEPHALEXIN | 50 of 190 | 1520 prescriptions Less than 1% of all prescriptions | 1320 | 1060 patients 20% of all patients | 910 patients 17% of all patients | A |
21 NITROFURANTOIN MONO-MACRO (NITROFURANTOIN MONOHYD/M-CRYST) | 110 of 200 | 620 prescriptions Less than 1% of all prescriptions | | 460 patients 8% of all patients | < 11 | A |
22 TESTOSTERONE | 20 of 30 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
23 LEVOFLOXACIN | 20 of 70 | 700 prescriptions Less than 1% of all prescriptions | | 540 patients 10% of all patients | < 11 | A |
24 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 40 of 90 | 410 prescriptions Less than 1% of all prescriptions | | 330 patients 6% of all patients | < 11 | A |
25 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 150 of 220 | 330 prescriptions Less than 1% of all prescriptions | | 260 patients 5% of all patients | < 11 | A |
26 AMOXICILLIN | 30 of 60 | 360 prescriptions Less than 1% of all prescriptions | | 270 patients 5% of all patients | < 11 | A |
27 CIPROFLOXACIN HCL | 170 of 230 | 380 prescriptions Less than 1% of all prescriptions | | 280 patients 5% of all patients | < 11 | A |
28 OXYCODONE-ACETAMINOPHEN (OXYCODONE HCL/ACETAMINOPHEN) | 70 of 130 | 400 prescriptions Less than 1% of all prescriptions | | 380 patients 7% of all patients | < 11 | O |
29 FLUCONAZOLE | 10 of 30 | 180 prescriptions Less than 1% of all prescriptions | | 130 patients 2% of all patients | < 11 | |